Mike Cusnir
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Surgical Treatments
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 16
- Pancreatic and Hepatic Oncology Research 6
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 3
- Colorectal Cancer Treatments and Studies 3
-
- Cancer Genomics and Diagnostics 5
- Co-authors
- Yehuda Z. Patt (1 shared paper)Ludimila L. Cavalcante (1 shared paper)Omar Issa (1 shared paper)Orlando Santana (1 shared paper)Michael L. Francavilla (3 shared papers)Christos G. Mihos (1 shared paper)Jeffrey Lin (1 shared paper)Simon Blechman Zeichner (3 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Annals of Oncology (3 papers)Cancers (1 paper)Translational Oncology (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Mike Cusnir
27 papers receiving 932 citations
Mike Cusnir's Hit Papers
Peers
Comparison fields: 5 of 62
- Oncology 531
- Cancer Research 141
- Pulmonary and Respiratory Medicine 132
- Pathology and Forensic Medicine 62
- Immunology 70
Countries citing papers authored by Mike Cusnir
This map shows the geographic impact of Mike Cusnir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Cusnir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Cusnir more than expected).
Fields of papers citing papers by Mike Cusnir
This network shows the impact of papers produced by Mike Cusnir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Cusnir. The network helps show where Mike Cusnir may publish in the future.
Co-authors
The 25 scholars most cited alongside Mike Cusnir, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study Hit paper breakdown → | 2022 | 235 |
| 2 | 2019 | 199 | |
| 3 | 2015 | 104 | |
| 4 | Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study Hit paper breakdown → | 2024 | 99 |
| 5 | 2024 | 86 | |
| 6 | 2019 | 50 | |
| 7 | 2004 | 25 | |
| 8 | 2012 | 22 | |
| 9 | 2014 | 19 | |
| 10 | 2025 | 19 | |
| 11 | 2025 | 17 | |
| 12 | 2015 | 15 | |
| 13 | 2012 | 13 | |
| 14 | 2016 | 13 | |
| 15 | 2010 | 7 | |
| 16 | 2013 | 7 | |
| 17 | 2011 | 5 | |
| 18 | 2022 | 5 | |
| 19 | Complete remission in 4 patients with human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin, a novel chemotherapy combination. | 2012 | 4 |
| 20 | 2020 | 3 |
About Mike Cusnir
Mike Cusnir is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Hematology, having authored 30 papers that have together received 955 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (6 papers), Cancer Genomics and Diagnostics (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), CAR-T cell therapy research (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Neuroendocrine Tumor Research Advances (2 papers), Genetic factors in colorectal cancer (2 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Oncology (531 citations), Cancer Research (141 citations), Pulmonary and Respiratory Medicine (132 citations), Pathology and Forensic Medicine (62 citations) and Immunology (70 citations). Mike Cusnir has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Yehuda Z. Patt, Ludimila L. Cavalcante, Omar Issa, Orlando Santana, Michael L. Francavilla, Christos G. Mihos, Jeffrey Lin, Simon Blechman Zeichner, Erin B. Kennedy and Manju George. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancers, Translational Oncology and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.